Showing results (121-130 of 1,185) with videos related to
Sort By:
Pageof 119
Nephron. Clinical Practice|September 20, 2008
The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new conceptsRoberto Pisoni, Keith M Wille, Ashita J TolwaniNephron. Clinical Practice|September 20, 2008
Biomarkers for the diagnosis of acute kidney injurySushrut S Waikar, Joseph V BonventreNephron. Clinical Practice|August 30, 2008
Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatmentG Jean, J C Terrat, T Vanel, et al.Nephron. Clinical Practice|September 11, 2008
Effect of high haematocrit on the efficiency of high-flux dialysis therapiesElaine M Spalding, Priya Pandya, Ken FarringtonNephron. Clinical Practice|July 11, 2009
Increased iron requirement in hemodialysis patients on antiplatelet agents or warfarinShaun Flint, Emma Taylor, Jennifer Beavis, et al.Nephron. Clinical Practice|August 13, 2009
A randomized controlled clinical trial comparing the efficacy of dead sea mineral-enriched body lotion versus two types of placebo in the treatment of cutaneous dryness, itching, peeling and tightness in hemodialysis patients (EDIT)Mona Boaz, Larisa Shtendik, Miriam Oron, et al.Nephron. Clinical Practice|August 13, 2009
Diminished benefits of drug-eluting stents versus bare metal stents in patients with severe renal insufficiencyMichael A Rosenblum, Michael J Robbins, Michael E Farkouh, et al.Nephron. Clinical Practice|September 25, 2007
Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin TClaudia Sommerer, Evangelos Giannitsis, Vedat Schwenger, et al.Nephron. Clinical Practice|September 25, 2007
Do biochemical measures change in living kidney donors? A systematic reviewAnn Young, Immaculate F P Nevis, Colin Geddes, et al.Nephron. Clinical Practice|September 25, 2007
A change from subcutaneous to intravenous erythropoietin increases the cost of anemia therapyPhilip A McFarlane, Michael P Hillmer, Niki DacourisPageof 119